0

Hypertension Collection
 21-40 of 649 Articles
Articles |  7 July 2009 FREE
Effect of Telmisartan on Renal Outcomes: A Randomized Trial
Johannes F.E. Mann, MD; Roland E. Schmieder, MD; Leanne Dyal, MSc; et al.
Ann Intern Med. 2009;151(1):1-10. doi:10.7326/0003-4819-151-1-200907070-00122
Articles |  7 July 2009 FREE
Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes: Three Randomized Trials
Rudy Bilous, MD; Nish Chaturvedi, MD; Anne Katrin Sjølie, MD; et al.
Ann Intern Med. 2009;151(1):11-20. doi:10.7326/0003-4819-151-1-200907070-00120
Reviews |  2 June 2009
Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension
James R. Sowers, MD; Adam Whaley-Connell, DO; Murray Epstein, MD
Ann Intern Med. 2009;150(11):776-783. doi:10.7326/0003-4819-150-11-200906020-00005
Academia and the Profession |  19 May 2009
Current Guidelines for Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin II–Receptor Antagonists in Chronic Kidney Disease: Is the Evidence Base Relevant to Older Adults?
Ann M. O'Hare, MD; James S. Kaufman, MD; Kenneth E. Covinsky, MD, MPH; et al.
Ann Intern Med. 2009;150(10):717-724. doi:10.7326/0003-4819-150-10-200905190-00010
Articles |  21 October 2008
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension: A Randomized Trial
Gérald Simonneau, MD; Lewis J. Rubin, MD; Nazzareno Galiè, MD; et al.
Ann Intern Med. 2008;149(8):521-530. doi:10.7326/0003-4819-149-8-200810210-00004
Articles |  15 July 2008
Prehypertension during Young Adulthood and Coronary Calcium Later in Life
Mark J. Pletcher, MD, MPH; Kirsten Bibbins-Domingo, PhD, MD; Cora E. Lewis, MD; et al.
Ann Intern Med. 2008;149(2):91-99. doi:10.7326/0003-4819-149-2-200807150-00005
Articles |  20 May 2008 FREE
The Role of Clinical Uncertainty in Treatment Decisions for Diabetic Patients with Uncontrolled Blood Pressure
Eve A. Kerr, MD, MPH; Brian J. Zikmund-Fisher, PhD; Mandi L. Klamerus, MPH; et al.
Ann Intern Med. 2008;148(10):717-727. doi:10.7326/0003-4819-148-10-200805200-00004
Editorials |  20 May 2008
It's Time to Overcome Clinical Inertia
Lawrence S. Phillips, MD; Jennifer G. Twombly, MD, PhD
Ann Intern Med. 2008;148(10):783-785. doi:10.7326/0003-4819-148-10-200805200-00011
Articles |  15 April 2008
Effect of Unrelated Comorbid Conditions on Hypertension Management
Barbara J. Turner, MD, MSEd; Christopher S. Hollenbeak, PhD; Mark Weiner, MD; et al.
Ann Intern Med. 2008;148(8):578-586. doi:10.7326/0003-4819-148-8-200804150-00002
Articles |  1 April 2008
Differences in Kidney Function and Incident Hypertension: The Multi-Ethnic Study of Atherosclerosis
Bryan Kestenbaum, MD, MS; Kyle D. Rudser, PhD; Ian H. de Boer, MD, MS; et al.
Ann Intern Med. 2008;148(7):501-508. doi:10.7326/0003-4819-148-7-200804010-00006
Academia and the Profession |  1 April 2008
Exploring the Geometry of Treatment Networks
Georgia Salanti, PhD; Fotini K. Kavvoura, MD; John P.A. Ioannidis, MD
Ann Intern Med. 2008;148(7):544-553. doi:10.7326/0003-4819-148-7-200804010-00011
Editorials |  4 March 2008
Trials That Matter: The Effect of a Fixed-Dose Combination of an Angiotensin-Converting Enzyme Inhibitor and a Diuretic on the Complications of Type 2 Diabetes
George L. Bakris, MD; Michael Berkwits, MD, MSCE, Deputy Editor
Ann Intern Med. 2008;148(5):400-401. doi:10.7326/0003-4819-148-5-200803040-00012
Articles |  15 January 2008
A Risk Score for Predicting Near-Term Incidence of Hypertension: The Framingham Heart Study
Nisha I. Parikh, MD, MPH; Michael J. Pencina, PhD; Thomas J. Wang, MD; et al.
Ann Intern Med. 2008;148(2):102-110. doi:10.7326/0003-4819-148-2-200801150-00005
Editorials |  1 January 2008 FREE
Inhibitors of the Renin–Angiotensin System: Proven Benefits, Unproven Safety
Patrick S. Parfrey, MD
Ann Intern Med. 2008;148(1):76-77. doi:10.7326/0003-4819-148-1-200801010-00191
Reviews |  1 January 2008 FREE
Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension
David B. Matchar, MD; Douglas C. McCrory, MD, MHS; Lori A. Orlando, MD, MHS; et al.
Ann Intern Med. 2008;148(1):16-29. doi:10.7326/0003-4819-148-1-200801010-00189
Reviews |  1 January 2008 FREE
Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
Regina Kunz, MD, MSc(Epi); Chris Friedrich, MD; Marcel Wolbers, PhD; et al.
Ann Intern Med. 2008;148(1):30-48. doi:10.7326/0003-4819-148-1-200801010-00190
Articles |  4 September 2007
Regression of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Less Hospitalization for Heart Failure in Hypertensive Patients
Peter M. Okin, MD; Richard B. Devereux, MD; Katherine E. Harris, DrPH; et al.
Ann Intern Med. 2007;147(5):311-319. doi:10.7326/0003-4819-147-5-200709040-00006
Editorials |  20 March 2007
Trials That Matter: Rosiglitazone, Ramipril, and the Prevention of Type 2 Diabetes
David M. Nathan, MD; Michael Berkwits, MSCE, Deputy Editor
Ann Intern Med. 2007;146(6):461-463. doi:10.7326/0003-4819-146-6-200703200-00015
Articles |  2 January 2007
Alcohol Consumption and Risk for Coronary Heart Disease among Men with Hypertension
Joline W.J. Beulens, MSc; Eric B. Rimm, ScD; Alberto Ascherio, MD, DrPH; et al.
Ann Intern Med. 2007;146(1):10-19. doi:10.7326/0003-4819-146-1-200701020-00004
Reviews |  1 August 2006
Meta-Analysis: Risk for Hypertension in Living Kidney Donors
Neil Boudville, MD; G. V. Ramesh Prasad, MD; Greg Knoll, MD, MSc; et al.
Ann Intern Med. 2006;145(3):185-196. doi:10.7326/0003-4819-145-3-200608010-00006
Advertisement

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)